STOCK TITAN

CRWV insider sale notice — 281,250 shares via Morgan Stanley, NASDAQ

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144 filing discloses a proposed sale of 281,250 shares of Common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $26,125,312.50. The shares were acquired as Founders Shares from the issuer on 12/27/2023 and payment was recorded on the same date. The filing lists 370,470,348 shares outstanding and indicates the approximate date of sale as 08/20/2025. No securities were reported sold in the prior three months, and the filer affirms they do not possess undisclosed material adverse information.

Positive

  • Required disclosure provided under Rule 144 detailing broker, quantity, acquisition date, and aggregate market value
  • Filer attests they do not possess undisclosed material adverse information, which is a regulatory safeguard

Negative

  • Insider intends to sell founder shares, which could increase available float when executed
  • Filing does not identify the selling person (name not provided in the excerpt), limiting investor ability to assess context

Insights

TL;DR: An insider filing to sell founder shares via Morgan Stanley for $26.1M on NASDAQ; routine disclosure, watch timing.

The filing documents a proposed sale of 281,250 common shares acquired as founders shares on 12/27/2023. The broker is Morgan Stanley Smith Barney LLC and the sale is slated for 08/20/2025. The filer affirms no undisclosed material adverse information. This is a standard Rule 144 notice enabling a restricted/controlled holder to publicly disclose an intended sale; it does not itself confirm execution or motive. For investors, the notice increases transparency about potential share supply but contains no new operational or financial performance data.

TL;DR: Governance disclosure completed for proposed founder-share sale; signature attestations included, no compliance exceptions noted.

The form includes required attestations regarding material information and references Rule 10b5-1 considerations. It lists broker details and acquisition history (founders shares from issuer dated 12/27/2023). There are no reported securities sales in the past three months. The filing meets procedural requirements for controlled/insider dispositions under Rule 144 but does not provide identities or any trading plan text. From a governance perspective, the document fulfills notice obligations without revealing nonpublic operational matters.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the CRWV Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 281,250 common shares via Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value of $26,125,312.50 and an approximate sale date of 08/20/2025.

When were the shares being sold originally acquired according to the filing?

The shares were acquired as Founders Shares from the issuer on 12/27/2023, with payment recorded the same date.

Does the filing report any securities sold by the filer in the past three months?

No. The section 'Securities Sold During The Past 3 Months' states Nothing to Report.

Which broker and exchange are listed in the filing for the proposed sale?

The broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza and the listed exchange is NASDAQ.

What attestations does the filer make in the Form 144?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 plan considerations.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature